Characteristics . | French-speaking Belgium . | Czech Republic . | Finland . | France . | Norway . | Romania . | Sweden . |
---|---|---|---|---|---|---|---|
Initiator | Board of French-speaking registry (GNFB) | Czech Society of Nephrology (CSN) | Board of Finnish Registry for Kidney Diseases | Board of French KRT Registry (REIN) | Ministry of Health | Romanian Association of Nephrology, Dialysis and Vascular Access | Board of Swedish Renal Registry (SRR) |
Financial and other support in addition to any support received from the hosting departments | Federal Ministry of Health (data collection system) | Czech Society of Nephrology | To be specified |
| Ministry of Health |
| Swedish Association of Local Authorities and Regions and clinic fees |
Objectives | |||||||
Epidemiological research | + | + | + | In the future | + | + | + |
Clinical research | + | + | + | − | + | In the future | + |
Health economics research | − | + | − | In the future | + | In the future | − |
Quality improvement (QI) through benchmarking | + | + | + | − | + | − | +a |
Understand access to KRT and conservative care | − | − | − | + | + | − | − |
Forecast future care needs | − | − | + | + | + | In the future | + |
Providing data for bundle payment | − | − | − | + | − | − | − |
Year of start | 2015 | 2009 | In preparation | 2019 | 2016 | 2018 | 2008 |
Obligatory data collection | No | No | No | Only for those collecting data for bundle payment | Yes | Yes | No |
CKD stages included | 1–5 | Serum creatinine >300 µmol/L in men and 250 µmol/L in womenb | 4–5 (eGFR dropping below 20 mL/min/1.73 m2) | 4–5 (since 2020 and 2019, respectively) | 5 | 1–5 | 4–5 (all centres include patients with eGFR dropping below 30 mL/min/1.73 m2; some centres include from 45 mL/min/1.73 m2) |
CKD patients included | |||||||
Age range | Adults only | Adults only | None | All ages | All ages | All ages | Adults only |
N | 2348 | 5816 | None | >2500 | 1615 | 15 601 | 47 804 |
Per cent coverage of CKD patients treated by nephrologists | Unknown | 40 | NA | Unknown | 65–85 | Unknown | 75% |
Participating centres (n/N) | 10/34 | 73/115 | None | 59/1233 | 26/26 | 80/unknown | 47/48 |
Publication of annual reports | In the future | Yes | In the future | In the future | Yes | Yes | Yes |
Characteristics . | French-speaking Belgium . | Czech Republic . | Finland . | France . | Norway . | Romania . | Sweden . |
---|---|---|---|---|---|---|---|
Initiator | Board of French-speaking registry (GNFB) | Czech Society of Nephrology (CSN) | Board of Finnish Registry for Kidney Diseases | Board of French KRT Registry (REIN) | Ministry of Health | Romanian Association of Nephrology, Dialysis and Vascular Access | Board of Swedish Renal Registry (SRR) |
Financial and other support in addition to any support received from the hosting departments | Federal Ministry of Health (data collection system) | Czech Society of Nephrology | To be specified |
| Ministry of Health |
| Swedish Association of Local Authorities and Regions and clinic fees |
Objectives | |||||||
Epidemiological research | + | + | + | In the future | + | + | + |
Clinical research | + | + | + | − | + | In the future | + |
Health economics research | − | + | − | In the future | + | In the future | − |
Quality improvement (QI) through benchmarking | + | + | + | − | + | − | +a |
Understand access to KRT and conservative care | − | − | − | + | + | − | − |
Forecast future care needs | − | − | + | + | + | In the future | + |
Providing data for bundle payment | − | − | − | + | − | − | − |
Year of start | 2015 | 2009 | In preparation | 2019 | 2016 | 2018 | 2008 |
Obligatory data collection | No | No | No | Only for those collecting data for bundle payment | Yes | Yes | No |
CKD stages included | 1–5 | Serum creatinine >300 µmol/L in men and 250 µmol/L in womenb | 4–5 (eGFR dropping below 20 mL/min/1.73 m2) | 4–5 (since 2020 and 2019, respectively) | 5 | 1–5 | 4–5 (all centres include patients with eGFR dropping below 30 mL/min/1.73 m2; some centres include from 45 mL/min/1.73 m2) |
CKD patients included | |||||||
Age range | Adults only | Adults only | None | All ages | All ages | All ages | Adults only |
N | 2348 | 5816 | None | >2500 | 1615 | 15 601 | 47 804 |
Per cent coverage of CKD patients treated by nephrologists | Unknown | 40 | NA | Unknown | 65–85 | Unknown | 75% |
Participating centres (n/N) | 10/34 | 73/115 | None | 59/1233 | 26/26 | 80/unknown | 47/48 |
Publication of annual reports | In the future | Yes | In the future | In the future | Yes | Yes | Yes |
QI benchmarks: blood pressure (percentage <140/90 mm/Hg), phosphate (percentage <1.6 mmol/L), haemoglobin 10–12 g/dL if on erythropoiesis-stimulating agent, percentage diagnosed with PRD, percentage on angiotensin-converting enzyme inhibitor/angiotensin II recpetor blocker if diabetic kidney disease.
eGFR determined by the Chronic Kidney Diease Epidemiology Collaboration equation available for further distribution of CKD stages.
Characteristics . | French-speaking Belgium . | Czech Republic . | Finland . | France . | Norway . | Romania . | Sweden . |
---|---|---|---|---|---|---|---|
Initiator | Board of French-speaking registry (GNFB) | Czech Society of Nephrology (CSN) | Board of Finnish Registry for Kidney Diseases | Board of French KRT Registry (REIN) | Ministry of Health | Romanian Association of Nephrology, Dialysis and Vascular Access | Board of Swedish Renal Registry (SRR) |
Financial and other support in addition to any support received from the hosting departments | Federal Ministry of Health (data collection system) | Czech Society of Nephrology | To be specified |
| Ministry of Health |
| Swedish Association of Local Authorities and Regions and clinic fees |
Objectives | |||||||
Epidemiological research | + | + | + | In the future | + | + | + |
Clinical research | + | + | + | − | + | In the future | + |
Health economics research | − | + | − | In the future | + | In the future | − |
Quality improvement (QI) through benchmarking | + | + | + | − | + | − | +a |
Understand access to KRT and conservative care | − | − | − | + | + | − | − |
Forecast future care needs | − | − | + | + | + | In the future | + |
Providing data for bundle payment | − | − | − | + | − | − | − |
Year of start | 2015 | 2009 | In preparation | 2019 | 2016 | 2018 | 2008 |
Obligatory data collection | No | No | No | Only for those collecting data for bundle payment | Yes | Yes | No |
CKD stages included | 1–5 | Serum creatinine >300 µmol/L in men and 250 µmol/L in womenb | 4–5 (eGFR dropping below 20 mL/min/1.73 m2) | 4–5 (since 2020 and 2019, respectively) | 5 | 1–5 | 4–5 (all centres include patients with eGFR dropping below 30 mL/min/1.73 m2; some centres include from 45 mL/min/1.73 m2) |
CKD patients included | |||||||
Age range | Adults only | Adults only | None | All ages | All ages | All ages | Adults only |
N | 2348 | 5816 | None | >2500 | 1615 | 15 601 | 47 804 |
Per cent coverage of CKD patients treated by nephrologists | Unknown | 40 | NA | Unknown | 65–85 | Unknown | 75% |
Participating centres (n/N) | 10/34 | 73/115 | None | 59/1233 | 26/26 | 80/unknown | 47/48 |
Publication of annual reports | In the future | Yes | In the future | In the future | Yes | Yes | Yes |
Characteristics . | French-speaking Belgium . | Czech Republic . | Finland . | France . | Norway . | Romania . | Sweden . |
---|---|---|---|---|---|---|---|
Initiator | Board of French-speaking registry (GNFB) | Czech Society of Nephrology (CSN) | Board of Finnish Registry for Kidney Diseases | Board of French KRT Registry (REIN) | Ministry of Health | Romanian Association of Nephrology, Dialysis and Vascular Access | Board of Swedish Renal Registry (SRR) |
Financial and other support in addition to any support received from the hosting departments | Federal Ministry of Health (data collection system) | Czech Society of Nephrology | To be specified |
| Ministry of Health |
| Swedish Association of Local Authorities and Regions and clinic fees |
Objectives | |||||||
Epidemiological research | + | + | + | In the future | + | + | + |
Clinical research | + | + | + | − | + | In the future | + |
Health economics research | − | + | − | In the future | + | In the future | − |
Quality improvement (QI) through benchmarking | + | + | + | − | + | − | +a |
Understand access to KRT and conservative care | − | − | − | + | + | − | − |
Forecast future care needs | − | − | + | + | + | In the future | + |
Providing data for bundle payment | − | − | − | + | − | − | − |
Year of start | 2015 | 2009 | In preparation | 2019 | 2016 | 2018 | 2008 |
Obligatory data collection | No | No | No | Only for those collecting data for bundle payment | Yes | Yes | No |
CKD stages included | 1–5 | Serum creatinine >300 µmol/L in men and 250 µmol/L in womenb | 4–5 (eGFR dropping below 20 mL/min/1.73 m2) | 4–5 (since 2020 and 2019, respectively) | 5 | 1–5 | 4–5 (all centres include patients with eGFR dropping below 30 mL/min/1.73 m2; some centres include from 45 mL/min/1.73 m2) |
CKD patients included | |||||||
Age range | Adults only | Adults only | None | All ages | All ages | All ages | Adults only |
N | 2348 | 5816 | None | >2500 | 1615 | 15 601 | 47 804 |
Per cent coverage of CKD patients treated by nephrologists | Unknown | 40 | NA | Unknown | 65–85 | Unknown | 75% |
Participating centres (n/N) | 10/34 | 73/115 | None | 59/1233 | 26/26 | 80/unknown | 47/48 |
Publication of annual reports | In the future | Yes | In the future | In the future | Yes | Yes | Yes |
QI benchmarks: blood pressure (percentage <140/90 mm/Hg), phosphate (percentage <1.6 mmol/L), haemoglobin 10–12 g/dL if on erythropoiesis-stimulating agent, percentage diagnosed with PRD, percentage on angiotensin-converting enzyme inhibitor/angiotensin II recpetor blocker if diabetic kidney disease.
eGFR determined by the Chronic Kidney Diease Epidemiology Collaboration equation available for further distribution of CKD stages.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.